Global Epilepsy Market 2014-2018


Naperville, IL -- (SBWire) -- 11/10/2014 --Reportstack, provider of premium market research reports announces the addition of Global Epilepsy Market 2014-2018 market report to its offering.

About Epilepsy
Epilepsy is defined as a spectrum of brain disorders varying from benign symptoms to severe, disabling, and life-threatening symptoms. It can be caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as occurs in majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. Seizures result from an imbalance between the inhibitory and excitatory signals of the brain leading to sudden-onset of excitation. The occurrence of two or more unprovoked seizures is an important criteria to diagnose a person with seizures as being epileptic.

Analysts forecast the Global Epilepsy market to grow at a CAGR of 5.06 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Epilepsy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of anti-epileptic drugs approved for the treatment of symptoms of epilepsy.

Global Epilepsy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Epilepsy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas

- APAC       


Key Vendors

- GlaxoSmithKline

- Pfizer


Other Prominent Vendors

- Abbvie

- Eisai

- F. Hoffmann-La Roche

- H. Lundbeck

- Janssen Pharmaceuticals

- Meda AB

- Novartis

- Shire

- Sunovion Pharmaceuticals

- Supernus Pharmaceuticals

- Upsher-Smith Laboratories

- Valeant Pharmaceuticals International

Market Driver

- Unmet Medical Needs

- For a full, detailed list, view our report

Market Challenge

- Generic Erosion

- For a full, detailed list, view our report

Market Trend

- Reformulation of Marketed Drugs

- For a full, detailed list, view our report

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the market opportunities and threats faced by the key vendors?

- What are the strengths and weaknesses of the key vendors?

Complete report is available @

Roger Campbell
United States
Ph: 888-789-6604

Media Relations Contact

Salil Modak
Director of Marketing

View this press release online at: